Federal Register / Vol. 84, No. 17 / Friday, January 25, 2019 / Notices 369 

ntp.niehs.nih.gov/go/36051 and will be 

updated one week before the meeting. 

Document Availability: The draft NTP 

monograph is available at https://

ntp.niehs.nih.gov/go/36051. 

Written Public Comment 

Submissions: Deadline was January 17, 

2019. 

Registration for Oral Comments: 

Deadline is January 28, 2019. 

Registration to View Webcast: 

Deadline is February 4, 2019. 

ADDRESSES:

Meeting Location: Webcast. 

Meeting web page: The draft NTP 

monograph, preliminary agenda, 

registration, and other meeting materials 

are available at https://

ntp.niehs.nih.gov/go/36051. 

Webcast: The URL for viewing the 

peer-review meeting webcast will be 

provided to registrants. 

This meeting notice is being 

published less than 15 days in advance 

of the meeting due to the partial 

Government shutdown of December 

2018. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Canden Byrd, ICF, 2635 Meridian 

Parkway, Suite 200, Durham, NC, USA 

27713. Phone: (919) 293–1660, Fax: 

(919) 293–1645, Email: NTP-Meetings@

icf.com. Dr. Elizabeth Maull, NIEHS/ 

DNTP, Designated Federal Official. 

Phone: (984) 287–3157, Email: maull@

niehs.nih.gov. 

SUPPLEMENTARY INFORMATION: 

Background: OHAT serves as an 

environmental health resource to the 

public and to regulatory and health 

agencies. This office conducts 

evaluations to assess the evidence that 

environmental chemicals, physical 

substances, or mixtures (collectively 

referred to as ‘‘substances’’) cause 

adverse health effects and provides 

opinions on whether these substances 

may be of concern given what is known 

about current human exposure levels. 

Sarin is a highly toxic 

organophosphorus nerve agent that was 

developed for chemical warfare during 

World War II and continues to be used 

as a weapon. The draft NTP monograph 

presents the results of the systematic 

review to evaluate the evidence for longterm neurological effects in humans 

following acute, sub-lethal exposure to 

sarin with consideration of human, 

experimental animal, and mechanistic 

date. 

Long-term neurological effects of 

acute exposure to sarin are not well 

characterized. Previous reviews of 

potential health effects of sarin have 

generally not assessed individual study 

quality or considered multiple evidence 

streams (human, animal, and 

mechanistic data). In addition, the 

interpretation of effects of sarin in some 

previous reviews was compounded by 

concurrent exposure to multiple 

chemicals, such as assessments of 

health effects in military personnel 

during the Gulf War or other conflicts. 

Meeting Attendance Registration: The 

meeting is open to the public with time 

set aside for oral public comment. 

Registration to view the webcast is open 

through February 4, 2019, and is found 

at https://ntp.niehs.nih.gov/go/36051. 

Registration is required to view the 

webcast; the URL for the webcast will be 

provided in the email confirming 

registration. Individuals with 

disabilities who need accommodation to 

view the webcast should contact 

Canden Byrd by phone: (919) 293–1660 

or email: NTP-Meetings@icf.com. TTY 

users should contact the Federal TTY 

Relay Service at (800) 877–8339. 

Requests should be made at least five 

business days in advance of the event. 

Public Comment Registration: NTP 

invites public comments on the draft 

NTP monograph that address scientific 

or technical issues. Guidelines for 

public comments are at https://

ntp.niehs.nih.gov/ntp/about_ntp/ 

guidelines_public_comments_508.pdf. 

The deadline for submission of written 

comments has passed. 

The agenda will allow for one oral 

public comment period (up to 12 

commenters, up to 5 minutes per 

speaker). Registration to provide oral 

comments is January 28, 2019, at 

https://ntp.niehs.nih.gov/go/36051. 

Registration will be on a first-come, 

first-served basis. Each organization will 

be allowed one time slot. Oral 

comments will be presented by 

teleconference line. The access number 

for the teleconference line will be 

provided to registrants by email prior to 

the meeting. Commenters will be 

notified approximately one week before 

the peer-review meeting about the 

actual time allotted per speaker. 

If possible, oral public commenters 

will be asked to send a copy of their 

slides and/or statement or talking points 

to Canden Byrd by email: NTPMeetings@icf.com by the registration 

deadline. 

Meeting Materials: The draft NTP 

monograph and preliminary agenda are 

available on the NTP website at https:// 

ntp.niehs.nih.gov/go/36051. Additional 

information will be posted when 

available or may be requested in 

hardcopy from Canden Byrd by phone: 

(919) 293–1660 or email: NTPMeetings@icf.com. Individuals are 

encouraged to access the meeting web 

page to stay abreast of the most current 

information regarding the meeting. 

Following the meeting, a report of the 

peer review will be prepared and made 

available on the NTP website. 

Background Information on NTP PeerReview Panels: NTP panels are 

technical, scientific advisory bodies 

established on an ‘‘as needed’’ basis to 

provide independent scientific peer 

review and advise NTP on agents of 

public health concern, new/revised 

toxicological test methods, or other 

issues. These panels help ensure 

transparent, unbiased, and scientifically 

rigorous input to the program for its use 

in making credible decisions about 

human hazard, setting research and 

testing priorities, and providing 

information to regulatory agencies about 

alternative methods for toxicity 

screening. NTP welcomes nominations 

of scientific experts for upcoming 

panels. Scientists interested in serving 

on an NTP panel should provide their 

current curriculum vitae to Canden 

Byrd by email: NTP-Meetings@icf.com. 

The authority for NTP panels is 

provided by 42 U.S.C. 217a; section 222 

of the Public Health Service Act, as 

amended. 

The panel is governed by the Federal 

Advisory Committee Act, as amended (5 

U.S.C. Appendix 2), which sets forth 

standards for the formation and use of 

advisory committees. 

Dated: January 17, 2019. 

Brian R. Berridge, 

Associate Director, National Toxicology 

Program. 

[FR Doc. 2019–00112 Filed 1–24–19; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Cell Biology 

Integrated Review Group; Nuclear and 


khammond on DSKBBV9HB2PROD with NOTICES
370 Federal Register / Vol. 84, No. 17 / Friday, January 25, 2019 / Notices 

Cytoplasmic Structure/Function and 

Dynamics Study Section. 

Date: January 31, 2019. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites Hotel, 4300 Military 

Road, Washington, DC 20015. 

Contact Person: Jessica Smith, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, jessica.smith6@nih.gov. 

This meeting notice is being published less 

than 15 days in advance of the meeting due 

to the partial Government shutdown of 

December 2018. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 18, 2019. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2019–00157 Filed 1–24–19; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Program Project I (P01) Review. 

Date: February 5–6, 2019. 

Time: 8:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville Hotel, 

1750 Rockville Pike, Rockville, MD 20852. 

Contact Person: Anita T. Tandle, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W248. 

Bethesda, MD 20892–9750, 240–276–5007, 

tandlea@mail.nih.gov. 

This meeting notice is being published less 

than 15 days in advance of the meeting due 

to the partial Government shutdown of 

December 2018. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: January 18, 2019. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2019–00155 Filed 1–24–19; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP—1B: 

SBIR Contract Review. 

Date: February 5, 2019. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

2W030, Rockville, MD 20850, (Telephone 

Conference Call). 

Contact Person: Ivan Ding, Ph.D. Scientific 

Review Officer, Program and Review 

Extramural Staff Training Office, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W534, Bethesda, MD 20892–9750, 

240–276–6444, dingi@mail.nih.gov. 

This meeting notice is being published less 

than 15 days in advance of the meeting due 

to the partial Government shutdown of 

December 2018. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: January 18, 2019. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2019–00156 Filed 1–24–19; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP—1C: 

SBIR Contract Review. 

Date: February 13, 2019. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

2W034, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Ivan Ding, Ph.D., Scientific 

Review Officer, Program and Review 

Extramural Staff Training Office, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W534, Bethesda, MD 20892–9750, 

240–276–6444, dingi@mail.nih.gov. 

This meeting notice is being published less 

than 15 days in advance of the meeting due 

to the partial Government shutdown of 

December 2018. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 


khammond on DSKBBV9HB2PROD with NOTICES